| Hassan Bazyar Imani, PHARMD | |
|
419 Marcos St, San Marcos, CA 92069-1509 | |
| (760) 847-7524 | |
| Not Available |
| Full Name | Hassan Bazyar Imani |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 419 Marcos St, San Marcos, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184238180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 83094 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hassan Bazyar Imani, PHARMD 419 Marcos St, San Marcos, CA 92069-1509 Ph: (760) 847-7524 | Hassan Bazyar Imani, PHARMD 419 Marcos St, San Marcos, CA 92069-1509 Ph: (760) 847-7524 |
News Archive
Kenall Manufacturing today introduced Indigo-Clean, a light fixture that uses Continuous Environmental Disinfection technology to continuously kill harmful bacteria linked to hospital acquired infections (HAIs). The technology behind Indigo-Clean inactivates a wide range of micro-organisms that are known causes of HAIs, including MRSA (Methicillin-resistant Staphylococcus aureus), C.difficile and VRE (Vancomycin-resistant Enterococcus).
A research team from the National Cancer Institute (NCI) designated Kimmel Cancer Center (KCC) at Jefferson has concluded for the first time that a multidisciplinary clinic approach to aggressive prostate cancer can improve survival in patients. The results from the 15-year study of the multidisciplinary clinic can be found in the November issue of Journal of Oncology Practice.
The Midwest Business Group on Health, one of the nation's leading business groups of private and public employers, will host its 31st Annual Conference for employers, health benefits professionals and other health care stakeholders, May 5-6, 2011 in Chicago. This year's theme is Health Benefits MEGATrends: Transformations in Health Care, Health Benefits & Health Improvement.
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a leading supplier of manufacturing solutions to the life sciences industries, announce today that they have received French Government funding through OSEO to finance the development of CER-001, a Cerenis HDL mimetic.
› Verified 2 days ago
Sonal Kirti Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 416 Camino Hermoso, San Marcos, CA 92078 Phone: 949-379-4022 | |
Michael Allen Lenzner, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2160 Coast Ave, San Marcos, CA 92078 Phone: 800-914-8771 Fax: 800-914-8772 | |
Amy Dollbaum, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 725 Center Dr, San Marcos, CA 92069 Phone: 760-871-6868 Fax: 760-871-6869 | |
Dr. Rose Ridings Feaver, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Craven Rd, San Marcos, CA 92078 Phone: 760-510-4077 Fax: 760-510-4450 | |
Evelyn Kwan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 191 Woodland Pkwy, San Marcos, CA 92069 Phone: 760-471-9007 Fax: 760-471-9785 | |
Minh Truong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 320 S Twin Oaks Valley Rd, San Marcos, CA 92078 Phone: 760-741-8014 | |
Lena Hanhduyen Pham, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 191 Woodland Pkwy, San Marcos, CA 92069 Phone: 760-471-9007 Fax: 760-471-9785 |